Collegium Pharmaceutical Inc (COLL)
Debt-to-assets ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 483,838 | 527,709 | 571,419 | 614,991 | 538,451 | 581,902 | 625,268 | 668,579 | 201,632 | 213,570 | 225,455 | 237,292 | 209,594 | 219,762 | 229,908 | 240,094 | 7,667 | 8,625 | 9,583 | 9,036 |
Total assets | US$ in thousands | 1,143,310 | 1,177,580 | 1,213,910 | 1,214,300 | 1,174,130 | 1,200,940 | 1,245,570 | 1,246,140 | 692,077 | 741,803 | 713,735 | 646,065 | 643,841 | 643,843 | 646,870 | 634,793 | 306,302 | 303,978 | 301,581 | 294,362 |
Debt-to-assets ratio | 0.42 | 0.45 | 0.47 | 0.51 | 0.46 | 0.48 | 0.50 | 0.54 | 0.29 | 0.29 | 0.32 | 0.37 | 0.33 | 0.34 | 0.36 | 0.38 | 0.03 | 0.03 | 0.03 | 0.03 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $483,838K ÷ $1,143,310K
= 0.42
The debt-to-assets ratio of Collegium Pharmaceutical Inc has shown some fluctuation over the past eight quarters, ranging from 0.58 to 0.66. This ratio indicates the proportion of the company's assets that are financed through debt. A higher debt-to-assets ratio suggests that a larger portion of the company's assets is funded by debt, which can signify higher financial risk due to potential difficulties in servicing debt obligations.
In the case of Collegium Pharmaceutical Inc, the ratio has hovered around 0.60 in most quarters, indicating a moderate level of leverage. The slight increase in the ratio from 0.58 in Q4 2022 to 0.66 in Q1 2023 may suggest a temporary increase in the company's reliance on debt to fund its assets. However, the subsequent decrease in Q2 and Q3 2023 to 0.62 and 0.60, respectively, may indicate efforts to manage debt levels and improve the overall financial stability of the company.
Overall, Collegium Pharmaceutical Inc's debt-to-assets ratio fluctuates within a relatively narrow range, suggesting a balanced approach to capital structure and financial risk management. It is important to monitor this ratio over time to assess the company's ability to sustain its debt obligations and support its asset base effectively.
Peer comparison
Dec 31, 2023